WallStreetZenWallStreetZen

NASDAQ: INSM
Insmed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for INSM

Based on 7 analysts offering 12 month price targets for Insmed Inc.
Min Forecast
$36.00+42.46%
Avg Forecast
$45.86+81.47%
Max Forecast
$55.00+117.65%

Should I buy or sell INSM stock?

Based on 7 analysts offering ratings for Insmed Inc.
Strong Buy
Strong Buy
6 analysts 85.71%
Buy
1 analysts 14.29%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INSM stock forecasts and price targets.

INSM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-23
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-02-27Find Out Why
lockedlocked$00.00+00.00%2024-02-27
Wolfe Research
Top 26%
75
BuyInitiates Coverage On$42.00+66.20%2024-02-15
JP Morgan
Top 12%
89
Strong BuyReinstates$36.00+42.46%2023-11-20

1 of 1

Forecast return on equity

Is INSM forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is INSM forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

INSM revenue forecast

What is INSM's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$356.0M+16.66%
Avg 2 year Forecast
$482.9M+58.21%
Avg 3 year Forecast
$762.9M+149.97%
INSM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INSM revenue growth forecast

How is INSM forecast to perform vs Biotechnology companies and vs the US market?
Company
33.87%
Industry
37.57%
Market
10.16%
INSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INSM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INSM$25.27$45.86+81.47%Strong Buy
RARE$45.11$87.70+94.41%Strong Buy
IBRX$5.49$5.00-8.93%Hold
AXSM$73.08$126.80+73.51%Strong Buy
IMVT$28.61$51.90+81.41%Strong Buy
View Top Biotech Stocks

Insmed Stock Forecast FAQ

Is Insmed Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: INSM) stock is to Strong Buy INSM stock.

Out of 7 analysts, 6 (85.71%) are recommending INSM as a Strong Buy, 1 (14.29%) are recommending INSM as a Buy, 0 (0%) are recommending INSM as a Hold, 0 (0%) are recommending INSM as a Sell, and 0 (0%) are recommending INSM as a Strong Sell.

If you're new to stock investing, here's how to buy Insmed stock.

What is INSM's revenue growth forecast for 2024-2026?

(NASDAQ: INSM) Insmed's forecast annual revenue growth rate of 33.87% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Insmed's revenue in 2024 is $305,208,000.On average, 5 Wall Street analysts forecast INSM's revenue for 2024 to be $52,869,834,161, with the lowest INSM revenue forecast at $51,986,903,208, and the highest INSM revenue forecast at $53,305,805,449. On average, 5 Wall Street analysts forecast INSM's revenue for 2025 to be $71,701,091,242, with the lowest INSM revenue forecast at $62,810,454,693, and the highest INSM revenue forecast at $89,251,608,420.

In 2026, INSM is forecast to generate $113,287,940,960 in revenue, with the lowest revenue forecast at $99,223,560,676 and the highest revenue forecast at $130,203,359,638.

What is INSM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: INSM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is INSM's Price Target?

According to 7 Wall Street analysts that have issued a 1 year INSM price target, the average INSM price target is $45.86, with the highest INSM stock price forecast at $55.00 and the lowest INSM stock price forecast at $36.00.

On average, Wall Street analysts predict that Insmed's share price could reach $45.86 by Apr 23, 2025. The average Insmed stock price prediction forecasts a potential upside of 81.47% from the current INSM share price of $25.27.

What is INSM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: INSM) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.